CytoRecovery Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $50K

  • Investors
  • 15

CytoRecovery General Information

Description

Developer of a label-free cell sorting platform designed to facilitate the recovery of rare cell populations. The company's platform utilizes microfluidic technology, dielectrophoresis and low-pressure fluidic systems to provide cell isolation, enrichment and characterization, enabling life sciences researchers and cell biologists to separate viable cell subpopulations from biological samples without the use of chemical markers or jet nozzles.

Contact Information

Formerly Known As
Phenochip
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1872 Pratt Drive
  • Suite 1350
  • Blacksburg, VA 24060
  • United States
+1 (540)
Primary Industry
Biotechnology
Vertical(s)
Corporate Office
  • 1872 Pratt Drive
  • Suite 1350
  • Blacksburg, VA 24060
  • United States
+1 (540)

CytoRecovery Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CytoRecovery Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
15. Later Stage VC 01-Aug-2026 $50K Completed Generating Revenue
14. Later Stage VC 24-Jun-2025 Completed Generating Revenue
13. Later Stage VC 01-Aug-2024 Completed Generating Revenue
12. Accelerator/Incubator 29-May-2024 Completed Generating Revenue
11. Later Stage VC 01-Oct-2023 Completed Generating Revenue
10. Accelerator/Incubator 08-Sep-2023 Completed Generating Revenue
9. Grant 09-Feb-2023 Completed Generating Revenue
8. Seed Round 05-Dec-2022 Completed Generating Revenue
7. Grant 07-Sep-2022 $75K $1.82M Completed Generating Revenue
6. Accelerator/Incubator 14-Jun-2022 $20K $1.82M Completed Generating Revenue
To view CytoRecovery’s complete valuation and funding history, request access »

CytoRecovery Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-2
Series A-1
To view CytoRecovery’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

CytoRecovery Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a label-free cell sorting platform designed to facilitate the recovery of rare cell populations. The compan
Biotechnology
Blacksburg, VA
4 As of 2026

Ann Arbor, MI
 

Vancouver, Canada
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

CytoRecovery Competitors (2)

One of CytoRecovery’s 2 competitors is Akadeum Life Sciences, a Venture Capital-Backed company based in Ann Arbor, MI.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Akadeum Life Sciences Venture Capital-Backed Ann Arbor, MI
STEMCELL Technologies Private Debt Financed Vancouver, Canada
You’re viewing 2 of 2 competitors. Get the full list »

CytoRecovery Patents

CytoRecovery Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240248061-A1 Dielectrophoresis and impedance devices for integration of electrical field-based particle sorting, enrichment, recovery, and characterization Pending 25-Jan-2023
US-20230241607-A1 Flexible material for use in microfluidic or microscale devices for cell or particle manipulation Pending 28-Jan-2022
CA-3148057-A1 Microfluidic package, holder, and methods of making and using the same Pending 19-Jul-2019
WO-2021016097-A2 Microfluidic package, holder, and methods of making and using the same Inactive 19-Jul-2019
WO-2021016097-A3 Microfluidic package, holder, and methods of making and using the same Inactive 19-Jul-2019 B01L3/502715
To view CytoRecovery’s complete patent history, request access »

CytoRecovery Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CytoRecovery Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds
UVA LVG Seed Fund Venture Capital Minority
Bloomfield Partners Growth/Expansion Minority
BioTools Innovator Accelerator/Incubator Minority
MedTech Innovator Accelerator/Incubator
Common Wealth Angels Angel Group Minority
You’re viewing 5 of 15 investors. Get the full list »

CytoRecovery FAQs

  • When was CytoRecovery founded?

    CytoRecovery was founded in 2017.

  • Where is CytoRecovery headquartered?

    CytoRecovery is headquartered in Blacksburg, VA.

  • What is the size of CytoRecovery?

    CytoRecovery has 4 total employees.

  • What industry is CytoRecovery in?

    CytoRecovery’s primary industry is Biotechnology.

  • Is CytoRecovery a private or public company?

    CytoRecovery is a Private company.

  • What is CytoRecovery’s current revenue?

    The current revenue for CytoRecovery is .

  • How much funding has CytoRecovery raised over time?

    CytoRecovery has raised $11.3M.

  • Who are CytoRecovery’s investors?

    UVA LVG Seed Fund, Bloomfield Partners, BioTools Innovator, MedTech Innovator, and Common Wealth Angels are 5 of 15 investors who have invested in CytoRecovery.

  • Who are CytoRecovery’s competitors?

    Akadeum Life Sciences and STEMCELL Technologies are competitors of CytoRecovery.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process